login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
EVOKE PHARMA INC (EVOK) Stock News
NASDAQ:EVOK -
US30049G3020
-
Common Stock
5.53
USD
-0.81 (-12.78%)
Last: 8/22/2025, 8:05:23 PM
4.94
USD
-0.59 (-10.67%)
After Hours:
8/22/2025, 8:05:23 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
EVOK Latest News, Press Relases and Analysis
All
Press Releases
16 hours ago - By: Chartmill
- Mentions:
GRO
PTIX
AEMD
GNPX
...
Wondering what's happening in today's pre-market session?
a day ago - By: Chartmill
- Mentions:
MSN
GRO
WDAY
MGNX
...
Thursday's after hours session: top gainers and losers
7 hours ago - By: Benzinga
- Mentions:
CSCI
NXL
ZYME
APLT
...
12 Health Care Stocks Moving In Friday's After-Market Session
16 hours ago - By: Benzinga
- Mentions:
PTIX
AEMD
CANF
OM
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
2 days ago - By: Chartmill
- Mentions:
LYTS
GRO
NCT
PTIX
...
These stocks that are showing activity before the opening bell on Thursday.
2 days ago - By: Evoke Pharma, Inc.
Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book
9 days ago - By: The Motley Fool
Evoke Pharma Posts 47 Percent Q2 Growth
9 days ago - By: Evoke Pharma, Inc.
Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
17 days ago - By: Evoke Pharma, Inc.
Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038
a month ago - By: Evoke Pharma, Inc.
Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036
3 months ago - By: Evoke Pharma, Inc.
Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: Evoke Pharma, Inc.
Evoke Pharma to Present New Data Comparing Tardive Dyskinesia Incidence in Continuous vs Intermittent Metoclopramide Use at DDW 2025
5 months ago - By: Evoke Pharma, Inc.
Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
6 months ago - By: Evoke Pharma, Inc.
Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025
6 months ago - By: Evoke Pharma, Inc.
Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors
8 months ago - By: Evoke Pharma, Inc.
Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
9 months ago - By: Evoke Pharma, Inc.
Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI®
10 months ago - By: Evoke Pharma, Inc.
Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
10 months ago - By: Evoke Pharma, Inc.
Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
10 months ago - By: Evoke Pharma, Inc.
Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
Please enable JavaScript to continue using this application.